Robin Smith Hoke is former President & Chief Executive Officer of Leiters (an SV portfolio company). Prior to joining Leiters, Ms. Hoke served as the Chair of the Board of Directors and Interim Chief Executive Officer at Ricerca Biosciences (an SV portfolio company), a private equity backed pre-clinical CRO.
Ms. Hoke also served as President of GeneraMedix, Inc., a generic and specialty pharmaceutical company serving the acute care market. Prior to GeneraMedix, she served in a variety of executive roles at Cardinal Health, including Senior Vice President of Global Business Development and Strategic Initiatives, Generic Pharmaceuticals, and General Counsel for Cardinal Health's Pharmaceutical Technologies & Services business. She has held legal roles at Abbott Laboratories and as a Partner in the business law firm of Kegler, Brown, Hill & Ritter, Co., L.P.A.
Ms. Hoke currently serves on the Boards of Directors of AeroSafe Global, a cold-chain service provider for the bio-pharma industry, and Catalyst Clinical Research, a CRO focused on oncology. She previously served on the boards of Aeterna Zentaris, a bio-pharmaceutical company that serves the needs of patients with rare endocrine diseases, and served as an Independent Director for Camargo Pharmaceuticals, LLC., a global 505B2 specialty company.
Academic credentials
Robin received her undergraduate degree from Michigan State University and her law degree from Cooley Law School.
